Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women

Maturitas

Volumn 59, Issue 4, 2008, Pages 339-349

  Hroussalas, Garifallia ^a   Kassi, Eva ^a   Dalamaga, Maria ^a   Delimaris, Ioannis ^a   Zachari, Ariadni ^a   Dionyssiou Asteriou, Amalia ^a  

^a Medical School   (Greece)

Author keywords

Adiponectin; Leptin; Obese postmenopausal woman; Oral glucose tolerance test; Resistin

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; RESISTIN;

ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; BODY FAT DISTRIBUTION; BODY MASS INDEX; COHORT STUDIES; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LEPTIN; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RECEPTORS, LEPTIN; RESISTIN;

EID: 44349140543     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.03.012     Document Type: Article

References (40)

1. Meier U., and Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50 (2004) 1511-1525
2. Speakman J.R., Stubbs R.J., and Mercer J.G. Does body mass play a role in the regulation of food intake?. Proc Nutr Soc 61 (2002) 473-487
3. Considine R.V., Sinha M.K., Heiman M.K., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 (1996) 292-295
4. Romon M., Lebel P., Fruchart J.C., and Dallongeville J. Postprandial leptin response to carbohydrate and fat meals in obese women. J Am Coll Nutr 22 (2003) 247-251
5. Yannakoulia M., Yiannakouris N., Bluher S., Matalas A.L., Klimis-Zacas D., and Mantzoros C.S. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88 (2003) 1730-1736
6. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148 (2003) 293-300
7. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 291 (2004) 1730-1737
8. Rea R., and Donelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?. Diabetes Obes Metab 6 (2004) 163-170
9. Lewandowski K.C., Szosland K., O'Callaghan C., Tan B.K., Randeva H.S., and Lewinski A. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab 85 (2005) 61-69
10. Osei K., Gaillard T., and Schuster D. Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes. Obes Res 13 (2005) 179-185
11. Hotta K., Funahashi T., Bodkin N.L., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50 (2001) 1126-1133
12. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130 (1999) 671-680
13. Thomas T., Burguera B., Melton III L.J., et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 49 (2000) 1278-1284
14. Savage D.B., Sewter C.P., Klenk E.S., et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in human. Diabetes 50 (2001) 2199-2202
15. Cheng C., Kushner H., and Falkner B.E. The utility of fasting glucose for detection of prediabetes. Metabolism 55 (2006) 434-438
16. Takahashi M., Funahashi T., Shimimura I., Miyaoka K., and Matsuzawa Y. Plasma leptin levels and body fat distribution. Horm Metab Res 28 (1996) 751-752
17. Hube F., Lietz U., Igel M., et al. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28 (1996) 690-693
18. Boden G., Chen X., Mozzoli M., and Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81 (1996) 3419-3423
19. Kolaczynski J.W., Ohannesian J.P., Considine R.V., Marco C.C., and Caro J.F. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 81 (1996) 4162-4165
20. Cammisotto P.G., Gelinas Y., Deshaies Y., and Bukowiecki L.J. Regulation of leptin secretion from white adipocytes by insulin, glycolytic substrates, and amino acids. Am J Physiolo Endocrinol Metab 289 (2005) E166-E171
21. Lopes I.M., Forga L., and Martinez J.A. Effects of leptin resistance on acute fuel metabolism after a high carbohydrate load in lean and overweight young men. J Am Coll Nutr 20 (2001) 643-648
22. Panarotto D., Ardilouze J.L., Tessier D., and Maxeux P. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm. Metabolism 49 (2000) 1055-1062
23. Cakir M., Sari R., Tosun O., and Karayalcin U. Leptin response to oral glucose tolerance test in obese and nonobese premenopausal women. Endocr Res 31 (2005) 1-8
24. Jazet I.M., Fogteloo A.J., and Meinders A.E. The relation between leptin and insulin remains when insulin secretion is disturbed. Eur J Intern Med 17 (2006) 109-114
25. Kolaczynski J.W., Nyce M.R., Considine R.V., et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45 (1996) 699-701
26. Sandhofer A., Laimer M., Ebenbichler C.F., Kaser S., Paulweber B., and Patsch J.R. Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. Obes Res 11 (2003) 760-768
27. Chan J.L., Bluher S., Yiannakouris N., Suchard M.A., Kratzsch J., and Mantzoros C.S. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51 (2002) 2105-2112
28. Sepilian V.P., Crochet J.R., and Naganami M. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril 85 (2006) 1441-1447
29. Ogawa T., Hirose H., Yamamoto Y., et al. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism 53 (2004) 879-885
30. Osei K., Gaillard T., Kaplow J., Bullock M., and Schuster D. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Metabolism 53 (2004) 1552-1557
31. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
32. Kim S.G., Ryu O.H., Kim H.Y., et al. Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome. Eur J Endocrinol 154 (2006) 433-440
33. Rasouli N., Yao-Borengasser A., Miles L.M., Elbein S.C., and Kern P.A. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Phys Endocrinol Metab 290 (2006) E42-E46
34. Monzillo L.U., Hamdy O., Horton E.S., et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11 (2003) 1048-1054
35. Smith S.R., Bai F., Charbonneau C., Janderova L., and Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52 (2003) 1611-1618
36. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
37. Pravenec M., Kazdova L., Landa V., et al. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 278 (2003) 45209-45215
38. Banerjee R.R., Rangwala S.M., Shapiro J.S., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
39. Kawashima J., Tsuruzoe K., Motoshima H., et al. Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 46 (2003) 231-240
40. Zhong Q., Lin C.Y., Clarke K.J., Kemppainen R.J., Schwartz D.D., and Judd R.L. Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 296 (2002) 383-387